{"nct_id":"NCT05446870","title":"Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002)","status":"COMPLETED","status_verified_date":"2025-09","start_date":"2022-07-25","start_date_type":"ACTUAL","primary_completion_date":"2023-12-20","primary_completion_date_type":"ACTUAL","completion_date":"2024-10-16","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}